ONCOLOGY OVERVIEW Flashcards
WHICH HIGHLY TOXIC DRUGS HAVE DOSING CONSIDERATIONS?
BLEOMYCIN
DOXORUBICIN
CISPLATIN
VINCRISTINE
BLEOMYCIN MAXIMUM DOSE
LIFETIME CUMULATIVE DOSE OF 400 UNITS
DOXORUBICIN MAXIMUM DOSE
LIFETIME CUMULATIVE DOSE OF 450 - 550 MG/M2
CISPLATIN MAXIMUM DOSE
DOSES PER CYCLE NOT TO EXCEED 100 MG/M2
VINCRISTINE MAXIMUM DOSE
SINGLE DOSE CAPPED AT 2 MG
WHAT IS THE REASON FOR THE MAX DOSE CAP FOR BLEOMYCIN
PULMONARY TOXICITY
WHAT IS THE REASON FOR THE MAX DOSE CAP FOR DOXORUBICIN
CARDIOTOXICITY
WHAT IS THE REASON FOR THE MAX DOSE CAP FOR CISPLATIN
NEPHROTOXICITY
WHAT IS THE REASON FOR THE MAX DOSE CAP FOR VINCRISTINE
NEUROPATHY
MOST AGENTS WILL CAUSE MYELOSUPPRESSION. WHICH ONES DO NOT?
ASPARAGINASE
BLEOMYCIN
VINCRISTINE
MABS AND TKIS
COMMMON DRUGS TO CAUSE N&V
CISPLATIN
CYCLOPHOSPHAMIDE
IFOSFAMIDE
COMMMON DRUGS TO CAUSE MUCOSITIS
FLUOROURACIL
METHOTREXATE
COMMMON DRUGS TO CAUSE DIARRHEA
IRINOTECAN
CAPECITABINE
FLUOROURCIL
METHOTREXATE
COMMMON DRUGS TO CAUSE CONSTIPATION
VINCRISTINE
COMMMON DRUGS TO CAUSE XEROSTOMIA
NONE
USUALLY CAUSED BY RADIATION
COMMMON DRUGS TO CAUSE CARDIOMYOPATHY
ANTHRACYCLINES
COMMMON DRUGS TO CAUSE QT PROLONGATION
ARSENIC TRIOXIDE
TKIS
COMMMON DRUGS TO CAUSE PULMONARY FIBROSIS
BLEOMYCIN
BUSULFAN
CARMUSTINE
LOMUSTINE
COMMMON DRUGS TO CAUSE PENUMONITIS
IMMUNE THERAPY MABS
COMMMON DRUGS TO CAUSE HEPATOTOXICITY
ANTIANDROGENS (BICALUTAMIDE, FLUTAMIDE, NILATAMIDE)
COMMMON DRUGS TO CAUSE NEPHROTOXICITY
CISPLATIN
METHOTREXATE
COMMMON DRUGS TO CAUSE HEMMORRHAGIC CYSTITIS
IFOSFAMIDE (ALL DOSES)
CYCLOPHOSPHAMIDE (HIGH DOSES)
COMMMON DRUGS TO CAUSE PERIPHERAL NEUROPATHY
VINCA ALKALOIDS
PLATINUMS
TAXANES
COMMMON DRUGS TO CAUSE AUTONOMIC NEUROPATHY
VINCA ALKALOIDS
COMMMON DRUGS TO CAUSE THROMBOEMBOLIC RISK (CLOTTING)
AROMATASE INHIBITORS
SERMS
NITROSUREAS MAJOR TOXICITY
NEUROTOXICITY
PLATINUM-BASED AGENTS MAJOR TOXICITY
NEPHROTOXIC
OTOTOXIC
METHOTREXATE MAJOR TOXICITY
MUCOSITIS
BLEOMYCIN, BUSULFAN, NITROSUREAS MAJOR TOXICITY
PULMONARY FIBROSIS
DOXORUBICIN AND OTHER ANTHRACYCLINES MAJOR TOXICITY
CARDIOTOXIC
IMMUNOTHERAPY MAJOR TOXICITY
WIDE SPREAD AUTOIMMUNE SYNDROMES
IFOSFAMIDE AND CYCLOPHOSPHAMIDE MAJOR TOXICITY
HEMORRHAGIC CYSTITIS
VINCA ALKALOIDS MAJOR TOXICITY
PERIPHERAL NEUROPATHY
TAXANES MAJOR TOXICITY
PERIPHERAL NEUROPATHY
MANAGEMENT FOR NEUTROPENIA
CSFs
MANAGEMENT FOR ANEMIA
RBC TRANSFUSIONS
ESAs FOR PALLIATIVE CARE ONLY
MANAGEMENT FOR N&V
NK1-RA
5HT3-RA
DEXAMETHASONE
IV/PO FLUID HYDRATION
MANAGEMENT FOR MUCOSITIS
SYMPTOMATIC TREATMENT
MANAGEMENT FOR DIARRHEA
IV/PO HYDRATION
ANTIMOTILITY AGENTS
MANAGEMENT FOR FOR IRINOTECAN DIARRHEA
ATROPINE FOR EARLY ONSET DIARRHEA
MANAGEMENT FOR CONSTIPATION
STIMULANT LAXATIVES
PEG 3350
MANAGEMENT FOR XEROSTOMIA
ARTIFICIAL SALIVA SUBSTITUTES
PILOCARPINE
CHEMO ADJUNCTIVE TO CISPLATIN AND WHY?
AMIFOSTINE (ETHYOL) AND HYDRATION
NEPHROTOXICITY PROPHYLAXIS
CHEMO ADJUNCTIVE TO DOXORUBICIN AND WHY
DEXRAZOXANE (ZINECARD, TOTECT)
CARDIOMYOPATHY PROPHYLAXIS
CHEMO ADJUNCTIVE TO FLUOROURACIL AND WHY
LEUCOVORIN OR LEVLEUCOVORIN (FUSILEV)
TO ENHANCE EFFICACY AS A COFACTOR
CHEMO ADJUNCTIVE TO FLUOROURACIL AND CAPECITABINE AND WHY
URIDINE TRACETATE (VISTOGARD)
ANTIDOTE
USE WITHIN 96 HOURS FOR AN OVERDOSE OR TO TREAT SEVERED LIFE THREATENING OR EARLY ONSET TOXICITY
CHEMO ADJUNCTIVE TO IFOSFAMIDE AND WHY
MESNA (MESNEX)
HEMORRHAGIC CYSTITIS PROPHYLAXIS
CHEMO ADJUNCTIVE TO IRINOTECAN ADN WHY
ATROPINE FOR ACUTE DIARRHEA
LOPERAMIDE FOR DELAYED DIARRHEA
CHEMO ADJUNCTIVE TO METHOTREXATE AND WHY
LEUCOVORIN OR LEVOLEUCOVORIN (FUSILEV) FOR MYELOSUPPRESSION AND MUCOSITIS PROPHYLAXIS
GLUCARPIDASE (VORAXAZE) IS AN ANTIDOTE FOR EXCESSIVE LEVELS